TuesdayJun 24, 2025 2:46 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model 

InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with high unmet medical needs, announced new preclinical data showing that INM-901 significantly reduces inflammation in ex vivo models of neuroinflammation. The compound demonstrated a dose-dependent and statistically significant reduction in pro-inflammatory cytokines IL-6, IL-1β, IL-2, KC/Gro, and inflammasome marker NLRP3—key factors in Alzheimer’s disease progression. Notably, the effects were independent of amyloid beta or tau pathology, highlighting INM-901’s broader potential in treating neurodegenerative diseases. The orally administered compound also targets CB1/CB2 receptors and PPARs and has shown improvements in cognition and behavior in long-term animal…

Continue Reading

WednesdayJun 18, 2025 2:23 pm

TinyGemsBreaks – Authentic Holdings (OTC: AHRO) Subsidiary Maybacks Global Launches Hit Broadcast of Ring of Combat via Swerve TV

Authentic Holdings (OTC: AHRO) announced a major licensing agreement between its subsidiary Maybacks Global Entertainment, LLC and Swerve TV, marked by a successful debut broadcast of "Ring of Combat" from the Tropicana in Atlantic City on June 13. The event exceeded expectations, drawing substantial viewership and social media traction across Swerve TV's extensive platform, which reaches 80% of U.S. and Canadian households and over 5 million combat sports fans. The collaboration showcased the legacy of "Ring of Combat," a promotion known for launching 165 fighters into the UFC, including champions like Matt Serra and Merab Dvalishvili. The broadcast success has…

Continue Reading

ThursdayJun 05, 2025 1:39 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Unveils Promising Data on CLD-401 at ASCO 2025

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the ability to deliver genetic payloads. The company unveiled promising new data on its lead RedTail platform candidate, CLD-401, at the American Society of Clinical Oncology (“ASCO”) Annual Meeting. The announcement reads, “Calidi has previously demonstrated its pioneering efforts in developing an enveloped form of its proprietary oncolytic virus that is significantly more resistant to immune clearance than non-enveloped forms, allowing for systemic delivery and efficacy in syngeneic tumor-bearing pre-clinical models. Calidi has further advanced this technology with CLD-401, its first…

Continue Reading

TuesdayJun 03, 2025 11:35 am

TinyGemsBreaks – ECGI Holdings Inc. (OTC: ECGI) Backs AI-Focused Startup TrueToForm in First Uplist Ventures Deal 

ECGI Holdings (OTC: ECGI), a diversified holding company targeting innovation-led sectors, announced that its investment arm, Uplist Ventures, has completed its first deal by backing AI and 3D computer vision startup TrueToForm. The startup, also backed by MassChallenge, Dartmouth Angels, and Chicago Booth Angels, offers a patented AI body scanning platform designed to reduce e-commerce apparel returns—a $38 billion problem—by creating 97%-accurate digital avatars. ECGI’s own Pacific Saddlery brand already uses TrueToForm for custom fittings. With over 50 clients and a pipeline of 25 brands, TrueToForm is scaling fast. ECGI executives said the deal signals the company’s strategy to support…

Continue Reading

TuesdayMay 27, 2025 11:36 am

TinyGemsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Passing of CEO Charles M. Fernandez, Appoints Interim Leadership 

NextPlat (NASDAQ: NXPL, NXPLW) announced with deep sadness the sudden passing of Executive Chairman and CEO Charles M. Fernandez on May 24. Fernandez had led the company since July 2021. The Board has appointed Rodney Barreto, Chair of the Audit Committee, as Interim Chairman, and David Phipps, current President and CEO of Global Operations, as Interim CEO. Vice Chairman Doug Ellenoff expressed condolences, noting Fernandez’s dedication to family and the company. Barreto, a director since 2022, brings over 35 years of business and civic leadership, while Phipps previously led NextPlat through its early growth and Nasdaq listing. The company is…

Continue Reading

TuesdayMay 27, 2025 10:16 am

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 6.9 MW Community Solar Project in Nova Scotia

Disseminated on behalf of SolarBank Corporation  SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will develop the 6.9 MW DC Brooklyn solar project in Nova Scotia under Canada’s first Community Solar Program. Owned by AI Renewable Fund, the $13.9 million project will be built in partnership with local firm Trimac Engineering. The program supports Nova Scotia’s goal of reaching 80% renewable energy by 2030 and net-zero by 2035. SolarBank will oversee interconnection, permitting, and design through 2025, with construction expected to begin in spring 2026. The company also disclosed a shares-for-services agreement with an independent advisor valued at up to…

Continue Reading

FridayMay 16, 2025 2:20 pm

TinyGemsBreaks – Capstone Holding Corp. (NASDAQ: CAPS) Reaffirms 2025 Guidance, Highlights M&A Pipeline and Flexible Growth Strategy 

Capstone Holding (NASDAQ: CAPS)  reaffirmed its 2025 targets of a $100 million revenue run-rate and $10 million in adjusted EBITDA, supported by a strong M&A pipeline and disciplined cost control. The company is evaluating acquisition opportunities at 4–6x EBITDA multiples, with up to 45% non-cash consideration, and has secured an equity line of credit to support deals without upfront dilution. Subsidiary Instone remained on track despite seasonal headwinds, with cost run-rate guidance intact and growth expected to pick up in Q3.  To view the full press release, visit https://ibn.fm/kwEhl  About Capstone Holding Corp.  Capstone Holding Corp. (NASDAQ: CAPS) is a…

Continue Reading

ThursdayMay 15, 2025 12:14 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Advances Redtail Virotherapy Platform and Reduces Q1 Losses

Calidi Biotherapeutics (NYSE American: CLDI) reported a Q1 2025 net loss of $5.0 million, narrowing from $7.2 million in the prior year, with R&D and G&A expenses also declining. The company highlighted FDA clearance of its IND for CLD-201, an allogeneic stem cell-based immunotherapy for solid tumors, and presented promising Redtail platform data at AACR showcasing IL15 superagonist delivery via engineered oncolytic virus. Calidi also announced key leadership additions, including CEO Dr. Eric Poma and CMO Dr. Guy Clifton, as it advances systemic virotherapies targeting metastatic cancers.  To view the full press release, visit: https://ibn.fm/TptuC  About Calidi Biotherapeutics  Calidi Biotherapeutics…

Continue Reading

ThursdayMay 15, 2025 11:01 am

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Report Q1 2025 Results and Host Investor Webinar Today 

Disseminated on behalf of SolarBank Corporation  SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will release its financial results for the quarter ended March 31, 2025, after market close today, May 15, and will host a webinar at 4:30 p.m. ET to provide a business update and discuss the quarterly performance.  To view the full press release, visit https://ibn.fm/PSk5q  About SolarBank Corporation  SolarBank Corporation is an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the USA. The Company develops solar, Battery Energy Storage System (BESS) and EV Charging projects that sell electricity…

Continue Reading

TuesdayMay 13, 2025 11:30 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Reaches Settlement Agreement with GEM Over Mishawaka Assets

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced it has executed a settlement agreement with GEM Yield Bahamas Limited and GEM Global Yield LLC SCS, resolving a four-year legal dispute. Under the agreement, GEM has a 55-day due diligence period—subject to extension—to evaluate the transfer of Mullen’s Mishawaka assets in full satisfaction of the judgment. All collection activities will be suspended during this period. Mullen stated it remains focused on expanding its Tunica, Mississippi, manufacturing operations to meet growing demand across its EV product lines.  To view the full press release, visit https://ibn.fm/Aks59  About Mullen Automotive Inc.  Mullen Automotive…

Continue Reading

Contact us: (512) 354-7000